Skip to main content
Equibles
USAQ logo

USAQ · QHSLab, Inc.

Track USAQ — free

Use USAQ with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.35 At close · Sep 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Despite the extinguishment of much of the Company's debt, the Company's history of losses combined with the amount of its revenues, raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 12, 2026
Market Cap
$5.26M
Shares
15.03M

USAQ metrics

55 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.35
Market cap
$5.26M

Price action

19 metrics
Price change (1W)
+7.7%
Price change (30D)
+0.0%
Price change (3M)
-22.4%
Price change (6M)
-42.6%
Price change (YTD)
-42.2%
Price change (1Y)
+86.2%
Trailing year
Price change (5Y)
-55.6%
52-week high
$0.92
52-week low
$0.08
Change from 52-week high
-62.0%
Change from 52-week low
+337.5%
Annualized volatility
273.7%
Beta
0.3
RSI (14D)
51.0
Price vs SMA 50
-12.6%
Price vs SMA 200
-13.3%
Avg volume (3M)
7,787
Relative volume
2.2
Average dollar volume
$2,350

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
15.03M

Valuation

12 metrics
P / E (TTM)
11.7
Trailing earnings · reciprocal yield 8.6%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 57.3%
P / book
3.4
reciprocal yield 29.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
67.7%
Operating margin
2.7%
Trailing 12 months
Net margin
-13.0%
Gross profit (TTM)
$2.04M
Operating profit (TTM)
$82,622
Net income (TTM)
−$390,726
Trailing 12 months
Diluted EPS (TTM)
$0.03
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.13

Growth

11 metrics
Revenue growth YoY
+40.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.02M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+104.6%
Year over year · more shares
Revenue CAGR (3Y)
+29.4%
Revenue CAGR (5Y)
+84.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-25.1%
Return on assets
-20.2%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
$154,734
Free cash flow (TTM)
—
Quick ratio
1.8
Interest coverage
0.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$317,392
Total assets
$1.93M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$463,663
Capital expenditures (TTM)
—
R&D (TTM)
$484,006
SG&A (TTM)
—
Stock compensation (TTM)
$0
R&D / revenue
16.0%
Stock compensation / revenue
0.0%

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 856984 Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)